Skip to main content
OpenTrials
Completed

NCT Number: NCT00000314

M-CPP and Fenfluramine in Cocaine Addicts - 3

The purpose of this study is to evaluate predictive value of M-CPP and fenfluramine challenges for outcome.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Cocaine-Related Disorders Chemically-Induced Disorders Mental Disorders Substance-Related Disorders

Age range

25 year–50 year

Sex eligibility

Male

Study type

Interventional

Phase

Phase 2

Primary location

VA Medical Center

Brooklyn, New York, 11209, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Please contact site for information.

Treatment and study plan

M-CPP

Drug

Primary outcomes

  1. Drug use

  2. Hospitalization, arrests, jail, employment, psychiataric symptoms

Sponsors and collaborators

Lead sponsor

National Institute on Drug Abuse (NIDA)

Nih

Collaborators

  • VA Office of Research and Development

Registry information

Official study title

To Study Predictive Values of M-CPP and Fenfluramine in Cocaine Addicts

Important dates

Study start
1994
Primary completion
1999
Study completion
1999
First posted
Sep 21, 1999
Registry last updated
Jan 18, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.